Regulation of tuberous sclerosis complex (TSC) function by 14-3-3 proteins

Area of Science:

• Genetics
• Molecular Biology
• Cell Signaling

Background:

• Tuberous sclerosis complex (TSC) is an autosomal dominant genetic disorder.
• TSC is characterized by the development of benign tumors (hamartomas) in multiple organs.
• Mutations in TSC1 or TSC2 tumor suppressor genes cause TSC by affecting the hamartin-tuberin protein complex.

Purpose of the Study:

• To elucidate the molecular mechanisms underlying TSC pathogenesis.
• To understand the role of the hamartin-tuberin complex in regulating cell signaling pathways.
• To investigate the interaction of tuberin with 14-3-3 proteins.

Main Methods:

• Analysis of the TSC1 and TSC2 genes and their protein products, hamartin and tuberin.
• Investigation of the hamartin-tuberin complex's function in phosphoinositide 3-kinase/protein kinase B/target of rapamycin (PI3K/AKT/mTOR) signaling.
• Study of phosphorylation-dependent interactions involving tuberin and 14-3-3 proteins.

Main Results:

• Inactivation of hamartin or tuberin leads to TSC.
• The hamartin-tuberin complex antagonizes the PI3K/AKT/mTOR pathway.
• This antagonism is achieved by inhibiting p70 S6 kinase and activating 4E-binding protein 1.
• Tuberin's interaction with 14-3-3 proteins is phosphorylation-dependent.

Conclusions:

• Dysregulation of the PI3K/AKT/mTOR pathway due to hamartin-tuberin complex inactivation is central to TSC.
• Understanding tuberin-14-3-3 interactions provides insights into the regulation of the hamartin-tuberin complex.
• These findings contribute to the molecular understanding of TSC and may inform therapeutic strategies.